{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:43:39Z","timestamp":1756385019405,"version":"3.44.0"},"reference-count":10,"publisher":"BMJ","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ Case Reports"],"abstract":"<jats:p>Medical treatment of pulmonary arterial hypertension (PAH) is increasingly common. Prostacyclins were introduced in the early 90s, and treprostinil is one of the most frequently used drugs of this class today, owing to its long half-life and to the possibility to administer the molecule through several routes. Treprostinil is considered a safe drug and is associated with a significant improvement of exercise capacity, especially in patients with idiopathic PAH (iPAH). Systemic sclerosis-associated PAH (sc-PAH) correlates to a worse prognosis compared with that of iPAH. Despite these considerations, safety data on treprostinil are still limited and mainly derived from randomised controlled trials and retrospective studies with relatively small and heterogeneous cohorts of patients with PAH. We report the occurrence of a severe intra-abdominal bleeding during treprostinil infusion in a patient with sc-PAH.<\/jats:p>","DOI":"10.1136\/bcr-2013-008677","type":"journal-article","created":{"date-parts":[[2013,2,28]],"date-time":"2013-02-28T15:51:43Z","timestamp":1362066703000},"page":"bcr2013008677","source":"Crossref","is-referenced-by-count":3,"title":["Intra-abdominal bleeding during treprostinil infusion in a patient with pulmonary arterial hypertension"],"prefix":"10.1136","volume":"2013","author":[{"given":"Stephanie","family":"Mindus","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine and Allergy, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacek","family":"Pawlowski","sequence":"additional","affiliation":[{"name":"Department of Radiology, Section of Thoracic Radiology, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magnus","family":"Nisell","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine and Allergy, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Ferrara","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine and Allergy, Karolinska University Hospital, Stockholm, Sweden"},{"name":"Department of Medicine, Section of Respiratory Diseases, University of Perugia, Perugia, Italy"},{"name":"Respiratory Medicine Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2013,2,27]]},"reference":[{"key":"2025082805071457000_2013.feb27_1.bcr2013008677.1","doi-asserted-by":"crossref","unstructured":"Paramothayan NS Lasserson TJ Wells AU . Prostacyclin for pulmonary hypertension in adults. Cochrane Database Syst Rev 2005;(2):CD002994.","DOI":"10.1002\/14651858.CD002994.pub2"},{"key":"2025082805071457000_2013.feb27_1.bcr2013008677.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2011.03.011"},{"key":"2025082805071457000_2013.feb27_1.bcr2013008677.3","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.06.00044406"},{"key":"2025082805071457000_2013.feb27_1.bcr2013008677.4","doi-asserted-by":"publisher","DOI":"10.1378\/chest.126.2.420"},{"key":"2025082805071457000_2013.feb27_1.bcr2013008677.5","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.165.6.2106079"},{"key":"2025082805071457000_2013.feb27_1.bcr2013008677.6","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-200302000-00019"},{"key":"2025082805071457000_2013.feb27_1.bcr2013008677.7","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1177\/112972980600700304","article-title":"Delivery of intravenous treprostinil at low infusion rates using a miniaturized infusion pump in patients with pulmonary arterial hypertension","volume":"7","author":"Tapson","year":"2006","journal-title":"J Vasc Access"},{"key":"2025082805071457000_2013.feb27_1.bcr2013008677.8","doi-asserted-by":"publisher","DOI":"10.1378\/chest.129.3.683"},{"key":"2025082805071457000_2013.feb27_1.bcr2013008677.9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/MAJ.0b013e31824184b1","article-title":"Epoprostenol-induced hypersplenism in portopulmonary hypertension","volume":"344","author":"Touma","year":"2012","journal-title":"Am J Med Sci"},{"key":"2025082805071457000_2013.feb27_1.bcr2013008677.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2010.03.008"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2013-008677","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:07:21Z","timestamp":1756382841000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2013-008677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,27]]},"references-count":10,"alternative-id":["10.1136\/bcr-2013-008677"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2013-008677","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2013,2,27]]}}}